The term "Mug1" (Murinoglobulin 1) appears in Search Result , describing a polyclonal antibody targeting mouse Murinoglobulin-1 (AA 700-910). Key characteristics include:
| Property | Detail |
|---|---|
| Target | Murinoglobulin 1 (Mug1) |
| Host Species | Rabbit |
| Applications | ELISA |
| Cross-Reactivity | Mouse-specific |
| Purification | >95% purity via Protein G |
If "mug10" is a typographical error for "Mug1," this antibody may represent the intended subject. Murinoglobulin-1 is a protease inhibitor involved in inflammatory responses and immune regulation.
To resolve ambiguity, consider the following:
Verify the antibody name (e.g., "Mug1" vs. "mug10") with the original source or context.
Explore homologs: The term "mug" may refer to murinoglobulin family proteins, which have human homologs (e.g., α2-macroglobulin).
Expand search criteria: Broaden the scope to include antibodies targeting murinoglobulin-like domains or conserved epitopes.
Structure: Pentameric/hexameric macro-immunoglobulins with high avidity for antigens .
Function: Neutralize pathogens, activate complement, and enhance mucosal immunity .
Mechanism: Binds a conserved trimerization interface, blocking viral entry and egress .
Efficacy: Demonstrated 100% lung protection in cotton rat models at 15 mg/kg .
Application: Checkpoint inhibitor for cancer immunotherapy .
Clinical Impact: Enhances T-cell responses in B-cell lymphoma and melanoma .
To address the absence of "mug10 Antibody" in current literature:
Database Searches: Query specialized repositories (e.g., UniProt, PubMed, Antibody Registry) for unpublished or proprietary antibodies.
Commercial Catalogs: Review antibody vendors (e.g., Thermo Fisher, Vector Labs) for "mug10" listings.
Technical Validation: If "mug10" is a novel target, initiate epitope mapping and hybridoma development.
KEGG: spo:SPAC57A10.04
STRING: 4896.SPAC57A10.04.1
MUG10 (Meiotically up-regulated gene 10) protein is a 39,121 Da protein expressed in Schizosaccharomyces pombe during meiotic processes. The significance of this protein lies in its specific expression pattern during meiosis, making it an important marker for studying meiotic regulation in fission yeast. Understanding MUG10's role contributes to our broader knowledge of meiotic processes across eukaryotes and provides insights into fundamental cellular mechanisms of sexual reproduction. Research on MUG10 helps elucidate how gene expression is regulated during the transition from mitotic to meiotic cell division in model organisms .
MUG10 antibody has been validated for several research applications, primarily:
Western Blot (WB): For detecting MUG10 protein in cell lysates and evaluating expression levels
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative assessment of MUG10 protein
These applications enable researchers to investigate MUG10 expression patterns during different cellular states, particularly during meiosis in fission yeast. When designing experiments, researchers should consider that each application requires specific optimization parameters to ensure reliable results .
When designing experiments with MUG10 antibody, researchers should implement multiple controls to ensure data validity:
Positive control: Samples known to express MUG10 protein (e.g., S. pombe cells during meiosis)
Negative control: Samples where MUG10 expression is absent (e.g., mitotic cells or knockout strains)
Isotype control: Rabbit IgG at the same concentration to identify non-specific binding
Loading control: For Western blots, include detection of housekeeping proteins to normalize protein loading
Peptide competition: Pre-incubation of the antibody with immunizing peptide to confirm specificity
This systematic approach to controls helps distinguish specific signals from background noise and validates experimental findings, similar to control strategies employed with other research antibodies .
For maintaining antibody integrity and experimental reproducibility, MUG10 antibody requires specific storage and handling conditions:
Storage temperature: Store at -20°C or -80°C upon receipt
Avoid repeated freeze-thaw cycles (aliquot upon first thaw if possible)
Storage buffer composition: 50% Glycerol, 0.01M PBS (pH 7.4), 0.03% Proclin 300 as preservative
If small volumes become entrapped in the vial cap during shipping, briefly centrifuge before opening
Working dilutions should be prepared fresh before use
For long-term storage, maintain in the presence of a carrier protein (e.g., 0.1% BSA)
Proper storage and handling are essential for maintaining antibody activity and ensuring consistent experimental results across multiple studies .
Epitope mapping for MUG10 antibody can be approached through several advanced techniques:
Phage display technology:
Create a peptide library expressing fragments of the MUG10 protein
Perform 3-4 rounds of biopanning against the MUG10 antibody
Select and sequence 50-60 individual phage clones that bind to the antibody
Analyze common motifs among selected peptides to identify the epitope
Alanine scanning mutagenesis:
Generate a series of MUG10 protein variants with systematic alanine substitutions
Test antibody binding to each mutant
Identify critical residues required for antibody recognition
Hydrogen-deuterium exchange mass spectrometry (HDX-MS):
Compare exchange rates between free MUG10 protein and antibody-bound MUG10
Regions with reduced exchange when bound to antibody likely constitute the epitope
This approach has been successfully applied to other antibodies, such as mAb 10H10, where epitope mapping revealed the recognition of conserved regions in the target protein .
Optimizing Western blot protocols for MUG10 antibody requires systematic adjustment of multiple parameters:
| Parameter | Optimization Strategy | Rationale |
|---|---|---|
| Antibody dilution | Test range from 1:500 to 1:5000 | Balance between signal strength and background |
| Blocking agent | Compare BSA vs. non-fat milk (3-5%) | Different proteins block different non-specific interactions |
| Incubation time | Test 1h at room temperature vs. overnight at 4°C | Longer incubation may increase sensitivity |
| Washing stringency | Optimize detergent concentration (0.05-0.3% Tween-20) | Removes non-specific binding without disrupting specific interactions |
| Detection system | Compare ECL vs. fluorescent detection | Different sensitivities and dynamic ranges |
Each parameter should be tested systematically while keeping others constant to identify optimal conditions. This approach ensures maximum sensitivity and specificity when detecting MUG10 protein in yeast samples, similar to optimization strategies used for other antibodies in research settings .
Assessing cross-reactivity is crucial for ensuring experimental specificity. For MUG10 antibody, researchers should implement a multi-faceted approach:
Bioinformatic prediction:
Identify proteins with sequence similarity to MUG10 in S. pombe
Evaluate conservation of the epitope region in related proteins
Predict potential cross-reactive proteins using alignment tools
Experimental validation:
Test against recombinant proteins with sequence similarity to MUG10
Perform Western blots on MUG10 knockout/knockdown samples
Compare wild-type vs. mutant expression patterns
Immunoprecipitation-mass spectrometry:
Perform IP with MUG10 antibody followed by LC-MS/MS analysis
Identify all proteins pulled down by the antibody
Compare to predicted interactome to identify non-specific binding
This systematic approach helps distinguish between specific signal and potential artifacts, similar to methods used to validate antibody specificity in other research contexts .
MUG10 protein interactions can be investigated using several complementary antibody-based techniques:
Co-immunoprecipitation (Co-IP):
Use MUG10 antibody to pull down the target protein and associated complexes
Identify interaction partners by Western blot or mass spectrometry
Compare interaction profiles under different cellular conditions (e.g., mitosis vs. meiosis)
Proximity Ligation Assay (PLA):
Use MUG10 antibody in combination with antibodies against suspected interaction partners
PLA produces fluorescent signals only when proteins are in close proximity (<40 nm)
Visualize interactions in their native cellular context
Bimolecular Fluorescence Complementation (BiFC):
Generate fusion proteins of MUG10 and potential partners with split fluorescent protein fragments
Use antibody to verify expression levels in parallel experiments
Fluorescence occurs only when proteins interact, bringing the fragments together
These methodologies provide complementary data about MUG10's interaction network, revealing both stable and transient interactions that may be functionally significant .
Understanding potential artifacts is crucial for accurate data interpretation:
| Error Type | Possible Causes | Mitigation Strategies |
|---|---|---|
| False positives | Non-specific binding, cross-reactivity, secondary antibody issues | Use stringent washing, titrate antibody, include blocking peptide controls |
| False negatives | Epitope masking, protein degradation, insufficient sensitivity | Try multiple extraction methods, add protease inhibitors, use signal amplification |
| Inconsistent results | Batch-to-batch variation, protocol inconsistencies | Validate each antibody lot, standardize protocols, maintain reference samples |
| Background issues | Insufficient blocking, high antibody concentration | Optimize blocking conditions, increase wash stringency, dilute antibody |
Implementing these mitigation strategies helps ensure reliable and reproducible results when using MUG10 antibody, similar to quality control approaches used with other research antibodies .
While MUG10 antibody is not specifically validated for immunofluorescence, researchers can establish this application through systematic optimization:
Fixation method optimization:
Compare paraformaldehyde (2-4%) vs. methanol fixation
Test different fixation durations (10-30 minutes)
Evaluate epitope preservation with each method
Permeabilization protocol:
Test different detergents (Triton X-100, saponin) at various concentrations
Optimize permeabilization time for balance between antibody access and structural preservation
Consider antigen retrieval methods if necessary
Antibody validation controls:
Include peptide competition controls
Compare staining pattern in known positive and negative samples
Correlate with GFP-tagged MUG10 expression pattern if available
Signal-to-noise optimization:
Test different antibody dilutions (1:100 to 1:1000)
Optimize blocking conditions and duration
Consider signal amplification systems for weak signals
This methodical approach helps establish reliable immunofluorescence protocols for studying MUG10 localization patterns during different stages of the yeast cell cycle .
Post-translational modifications (PTMs) of MUG10 can be investigated through several complementary approaches:
Immunoprecipitation-based strategies:
Use MUG10 antibody to immunoprecipitate the protein
Probe for specific modifications using PTM-specific antibodies (phospho, ubiquitin, etc.)
Analyze by mass spectrometry to identify all modifications present
2D gel electrophoresis:
Separate proteins by isoelectric point and molecular weight
Detect MUG10 using the antibody via Western blot
Identify modified forms by altered migration patterns
Enzymatic treatments:
Treat samples with phosphatases, deglycosylation enzymes, etc., before Western blot
Compare migration patterns before and after treatment
Shifts in mobility indicate the presence of specific modifications
Phospho-specific analyses:
Use phospho-specific staining after IP with MUG10 antibody
Compare samples with and without phosphatase inhibitor treatment
Identify phosphorylation sites by mass spectrometry
These approaches provide insights into how PTMs regulate MUG10 function during different cellular processes in fission yeast .
For accurate quantitative analysis of MUG10 protein levels:
Standard curve establishment:
Use purified recombinant MUG10 protein at known concentrations
Generate standard curves under the same conditions as experimental samples
Ensure detection is within the linear range of the assay
Normalization strategies:
For Western blot: Normalize to housekeeping proteins (tubulin, actin)
For ELISA: Use total protein concentration for normalization
Consider spike-in controls for sample-to-sample comparison
Technical replication:
Perform at least three technical replicates per biological sample
Calculate coefficients of variation to ensure reliability
Establish acceptance criteria for technical variability
Statistical considerations:
Determine appropriate statistical tests based on data distribution
Account for multiple comparisons when analyzing across conditions
Report confidence intervals along with means/medians
Following these guidelines ensures that quantitative measurements of MUG10 are reproducible and statistically sound .
MUG10 antibody provides a valuable tool for investigating meiotic processes:
Temporal expression profiling:
Monitor MUG10 protein levels throughout meiotic progression via Western blot
Correlate expression with key meiotic events (DNA replication, recombination, division)
Compare with other meiotic markers to establish regulatory relationships
Chromatin association studies:
Perform chromatin immunoprecipitation (ChIP) for proteins that might regulate MUG10
Analyze enrichment at the MUG10 gene locus
Compare chromatin marks during mitosis vs. meiosis to identify regulatory mechanisms
Genetic interaction mapping:
Analyze MUG10 protein expression in various meiotic mutant backgrounds
Establish epistatic relationships between MUG10 and other meiotic regulators
Construct regulatory networks governing meiotic progression
Stress response analysis:
Investigate how environmental stressors affect MUG10 expression
Determine if MUG10 is involved in stress-responsive meiotic regulation
Compare normal and stress conditions to identify regulatory mechanisms
These approaches help establish MUG10's position in the complex regulatory network controlling meiosis in fission yeast .
Several cutting-edge technologies offer new possibilities for MUG10 research:
Proximity labeling:
Generate MUG10 fusion proteins with BioID or APEX2
Use MUG10 antibody to confirm expression and localization
Identify proteins in close proximity to MUG10 in living cells
Super-resolution microscopy:
Apply STORM, PALM, or STED microscopy with MUG10 antibody
Achieve nanoscale resolution of MUG10 localization
Correlate with other cellular structures beyond diffraction limit
Single-cell proteomics:
Use mass cytometry (CyTOF) with metal-conjugated MUG10 antibody
Correlate MUG10 expression with dozens of other proteins at single-cell resolution
Identify cell subpopulations with distinct MUG10 expression patterns
Antibody engineering:
Develop recombinant antibody fragments (Fab, scFv) against MUG10
Create bispecific antibodies to study MUG10 in complex with other proteins
Engineer antibodies with enhanced properties for specific applications
These emerging technologies will provide unprecedented insights into MUG10 function, regulation, and interactions in fission yeast cells .
Integration of antibody-based protein detection with genomic and transcriptomic data provides a comprehensive understanding of MUG10 biology:
ChIP-seq integration:
Perform ChIP-seq for transcription factors binding to MUG10 promoter
Correlate binding patterns with protein expression detected by antibody
Identify regulatory elements controlling MUG10 expression
RNA-seq correlation:
Compare MUG10 mRNA levels (RNA-seq) with protein levels (Western blot)
Identify potential post-transcriptional regulation
Analyze correlation patterns across different cellular conditions
CRISPR screening validation:
Perform CRISPR screens to identify regulators of MUG10
Validate hits using MUG10 antibody to confirm protein-level effects
Distinguish transcriptional vs. post-transcriptional regulation
Multi-omics data integration:
Combine proteomics, transcriptomics, and genomics data
Create integrated regulatory models of MUG10 expression
Validate predictions using targeted experiments with MUG10 antibody
This multi-layered approach provides a systems-level understanding of MUG10 regulation and function in cellular processes .
Comparative analysis of MUG10 across species provides evolutionary insights:
Cross-species reactivity testing:
Evaluate MUG10 antibody reactivity with homologs in related yeast species
Determine epitope conservation through sequence alignment
Test antibody on lysates from multiple yeast species
Functional conservation analysis:
Compare expression patterns of MUG10 homologs during meiosis
Analyze phenotypes of MUG10 mutations across species
Use antibody to track protein expression in complementation studies
Structural comparison:
Predict protein structures of MUG10 homologs
Identify conserved domains that might be recognized by the antibody
Correlate structural features with functional conservation
Heterologous expression studies:
Express MUG10 homologs from different species in S. pombe
Use antibody to detect expression levels and localization
Determine functional complementation across species
This evolutionary perspective helps identify conserved aspects of MUG10 function that are likely to be fundamental to meiotic processes across fungi .
A robust experimental design for studying MUG10 during meiosis should include:
Synchronization protocol optimization:
Test different methods for synchronizing cells at meiotic entry
Validate synchrony using established meiotic markers
Collect samples at defined timepoints throughout meiotic progression
Multi-level analysis platform:
Protein level: Western blot with MUG10 antibody
Transcript level: RT-qPCR or RNA-seq for MUG10 mRNA
Genetic level: Reporter constructs to track promoter activity
Control samples:
Positive controls: Strains overexpressing MUG10
Negative controls: MUG10 deletion strains
Comparative controls: Strains with tagged MUG10 (GFP, FLAG, etc.)
Perturbation experiments:
Chemical inhibitors of meiotic processes
Genetic mutations in meiotic regulatory pathways
Environmental stress conditions that affect meiosis
This comprehensive approach ensures reliable characterization of MUG10 expression patterns and regulatory mechanisms during meiosis .
Ensuring reproducibility requires standardization of multiple experimental parameters:
Antibody validation documentation:
Record lot number and source of antibody
Document validation experiments performed (specificity, sensitivity)
Maintain reference samples for cross-batch comparison
Detailed protocol documentation:
Record all buffer compositions precisely
Document incubation times, temperatures, and washing procedures
Specify equipment settings (exposure times, gain settings, etc.)
Quantification standards:
Include calibration samples in each experiment
Use consistent quantification methods across studies
Report raw data alongside normalized results
Metadata reporting:
Document strain backgrounds and genetic modifications
Record growth conditions and media compositions
Note any deviations from standard protocols
Adherence to these practices enables meaningful comparison of results across different studies and laboratories, enhancing the collective knowledge about MUG10 biology .